glp-1 contraindications thyroid Glucagon-like peptide 1 receptor agonist use and risk of cancer: Scandinavian cohort study Does GLP-1 Help with Hashimoto's

Is there a community or support group

& Hirota, J

In the LEADER trial, over 9,340 patients with type 2 diabetes and high cardiovascular disease risk underwent randomization to liraglutide or placebo and were followed for a median of 3.8 years resulting in a 13% risk reduction in a combined endpoint of death from cardiovascular cause, nonfatal myocardial infarction, or nonfatal stroke [46]

Unlike older ultrasound or radiofrequency technologies that can penetrate too deeply and affect the fat layer beneath the skin, Sofwaves energy is confined to the skin itself, where collagen stimulation is most beneficial

However, while the technology shows promise, current clinical data remains limited